scholarly article | Q13442814 |
P50 | author | Subinoy Rana | Q41021991 |
Vincent Rotello | Q43900549 | ||
P2093 | author name string | Oscar R Miranda | |
Resham Bhattacharya | |||
Priyabrata Mukherjee | |||
Rochelle R Arvizo | |||
P2860 | cites work | Basic fibroblast growth factor is a β-rich protein | Q44386606 |
Rare earth nanoparticles prevent retinal degeneration induced by intracellular peroxides | Q44901406 | ||
Charge dependence of ligand release and monolayer stability of gold nanoparticles by biogenic thiols | Q46540520 | ||
Regulatory role of dynamin-2 in VEGFR-2/KDR-mediated endothelial signaling | Q46622520 | ||
Detection and identification of proteins using nanoparticle-fluorescent polymer 'chemical nose' sensors | Q47432468 | ||
Toxicity of Gold Nanoparticles Functionalized with Cationic and Anionic Side Chains | Q56443622 | ||
Angiogenesis | Q56689455 | ||
Gum arabic as a phytochemical construct for the stabilization of gold nanoparticles: in vivo pharmacokinetics and X-ray-contrast-imaging studies | Q79688038 | ||
Biomimetic interactions of proteins with functionalized nanoparticles: a thermodynamic study | Q80728755 | ||
Surface-anchoring of spontaneously dimerized epidermal growth factor for highly selective expansion of neural stem cells | Q83204488 | ||
Nanoparticles, Proteins, and Nucleic Acids: Biotechnology Meets Materials Science | Q88522298 | ||
The biology of VEGF and its receptors | Q27860704 | ||
Angiogenesis in cancer and other diseases | Q27861015 | ||
Mechanisms of angiogenesis | Q29547485 | ||
Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer | Q29614302 | ||
Cancer nanotechnology: opportunities and challenges | Q29615481 | ||
Gold nanoparticles: assembly, supramolecular chemistry, quantum-size-related properties, and applications toward biology, catalysis, and nanotechnology | Q29617209 | ||
Angiogenesis as a therapeutic target | Q29619525 | ||
Control of protein structure and function through surface recognition by tailored nanoparticle scaffolds. | Q30336329 | ||
Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles. | Q30489569 | ||
Selective cell targeting with light-absorbing microparticles and nanoparticles | Q30539080 | ||
Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles | Q33224381 | ||
Gold nanoparticles for biology and medicine | Q33558781 | ||
A current review of targeted therapeutics for ovarian cancer | Q33580998 | ||
A therapeutic aptamer inhibits angiogenesis by specifically targeting the heparin binding domain of VEGF165 | Q34245063 | ||
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer | Q35419004 | ||
Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis | Q35808025 | ||
Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis | Q36371903 | ||
Biological properties of "naked" metal nanoparticles | Q37172625 | ||
Gold nanoparticles in delivery applications | Q37191739 | ||
Gold nanoparticles in nanomedicine: preparations, imaging, diagnostics, therapies and toxicity | Q37545481 | ||
Effect of surface properties on nanoparticle-cell interactions | Q37618632 | ||
Fabrication of Ag@SiO(2)@Y(2)O(3):Er nanostructures for bioimaging: tuning of the upconversion fluorescence with silver nanoparticles | Q39739021 | ||
Noninvasive radiofrequency field-induced hyperthermic cytotoxicity in human cancer cells using cetuximab-targeted gold nanoparticles. | Q39882190 | ||
Shape-controlled synthesis of protein-conjugated silver sulfide nanocrystals and study on the inhibition of tumor cell viability | Q39952734 | ||
Targeted delivery of gemcitabine to pancreatic adenocarcinoma using cetuximab as a targeting agent | Q40002504 | ||
Intracellular gold nanoparticles enhance non-invasive radiofrequency thermal destruction of human gastrointestinal cancer cells | Q40018923 | ||
Antiangiogenic properties of gold nanoparticles | Q40427876 | ||
Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes | Q41144493 | ||
Polyphosphate blocks tumour metastasis via anti-angiogenic activity | Q42155924 | ||
Size limitation in translocation of fibroblast growth factor 1 fusion proteins across the endosomal membrane | Q42797739 | ||
Gold and silver nanoparticles conjugated with heparin derivative possess anti-angiogenesis properties | Q43262967 | ||
P433 | issue | 5 | |
P921 | main subject | nanotechnology | Q11468 |
nanoparticle | Q61231 | ||
angiogenesis inhibitor | Q574834 | ||
P304 | page(s) | 580-587 | |
P577 | publication date | 2011-02-17 | |
P1433 | published in | Nanomedicine: Nanotechnology, Biology and Medicine | Q6964073 |
P1476 | title | Mechanism of anti-angiogenic property of gold nanoparticles: role of nanoparticle size and surface charge | |
P478 | volume | 7 |
Q55362306 | Antiangiogenic and antiapoptotic effects of green-synthesized zinc oxide nanoparticles using Sargassum muticum algae extraction. |
Q92354274 | Antiangiogenic properties of nanoparticles: a systematic review |
Q38491805 | Aptamer-Functionalized Nanoparticles as "Smart Bombs": The Unrealized Potential for Personalized Medicine and Targeted Cancer Treatment |
Q37378292 | Balancing cationic and hydrophobic content of PEGylated siRNA polyplexes enhances endosome escape, stability, blood circulation time, and bioactivity in vivo |
Q53722751 | Capacity of gold nanoparticles in cancer radiotherapy. |
Q39368839 | Combination of nanotechnology with vascular targeting agents for effective cancer therapy. |
Q54379435 | Cuprous oxide nanoparticles inhibit angiogenesis via down regulation of VEGFR2 expression. |
Q47119535 | Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics. |
Q64068522 | Effect of gold nanoparticles treatment on the testosterone-induced benign prostatic hyperplasia in rats |
Q35181996 | Effects of internalized gold nanoparticles with respect to cytotoxicity and invasion activity in lung cancer cells |
Q27010637 | Epigenetics advancing personalized nanomedicine in cancer therapy |
Q51376589 | Gold Nanoparticle Reprograms Pancreatic Tumor Microenvironment and Inhibits Tumor Growth. |
Q91851450 | Gold Nanoparticles Disrupt Tumor Microenvironment - Endothelial Cell Cross Talk To Inhibit Angiogenic Phenotypes in Vitro |
Q93082256 | Gold Nanorod-Assisted Photothermal Therapy Decreases Bleeding during Breast Cancer Surgery in Dogs and Cats |
Q38435105 | Gold nanoparticle-aided brachytherapy with vascular dose painting: estimation of dose enhancement to the tumor endothelial cell nucleus |
Q90397600 | Gold nanoparticles and angiogenesis: molecular mechanisms and biomedical applications |
Q42819959 | Gold nanoparticles attenuates antimycin A-induced mitochondrial dysfunction in MC3T3-E1 osteoblastic cells |
Q37739975 | Gold nanoparticles enhance TRAIL sensitivity through Drp1-mediated apoptotic and autophagic mitochondrial fission in NSCLC cells |
Q57817200 | Gold nanoparticles enhance cisplatin delivery and potentiate chemotherapy by decompressing colorectal cancer vessels |
Q99584564 | Gold nanoparticles inhibit activation of cancer-associated fibroblasts by disrupting communication from tumor and microenvironmental cells |
Q38855626 | Gold nanoparticles: A critical review of therapeutic applications and toxicological aspects. |
Q38640947 | Gold-Based Nanomaterials for Applications in Nanomedicine. |
Q35839945 | Identifying new therapeutic targets via modulation of protein corona formation by engineered nanoparticles |
Q34612876 | In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice |
Q28487715 | Inhibiting the growth of pancreatic adenocarcinoma in vitro and in vivo through targeted treatment with designer gold nanotherapeutics |
Q36799216 | Inhibition of tumor growth and metastasis by a self-therapeutic nanoparticle |
Q35487583 | Inhibitory effect of gold nanoparticles on the D-ribose glycation of bovine serum albumin |
Q35942437 | Intrinsic therapeutic applications of noble metal nanoparticles: past, present and future |
Q92592099 | Nanoparticle Interactions with the Tumor Microenvironment |
Q39329359 | Nanoparticles as new tools for inhibition of cancer angiogenesis |
Q39429294 | Nanoparticles of carbon allotropes inhibit glioblastoma multiforme angiogenesis in ovo. |
Q93048600 | Nanotheranostics Targeting the Tumor Microenvironment |
Q30707089 | Preparation and characterization of Au nanoparticles capped with mercaptocarboranyl clusters. |
Q59489392 | Probing Cellular Processes Using Engineered Nanoparticles |
Q36929055 | Probing novel roles of the mitochondrial uniporter in ovarian cancer cells using nanoparticles |
Q42263911 | Protection against osteoarthritis in experimental animals by nanogold conjugated snake venom protein toxin gold nanoparticle-Naja kaouthia cytotoxin 1. |
Q89497296 | Role of Sirtuins in Tumor Angiogenesis |
Q34227763 | Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles |
Q53194416 | Structural characterization of functionalized gold nanoparticles for drug delivery in cancer therapy: a NMR based approach. |
Q92809805 | Synergistic Radiosensitization by Gold Nanoparticles and the Histone Deacetylase Inhibitor SAHA in 2D and 3D Cancer Cell Cultures |
Q40468972 | The Interplay of Size and Surface Functionality on the Cellular Uptake of Sub-10 nm Gold Nanoparticles. |
Q38805034 | Therapeutic application of anti-angiogenic nanomaterials in cancers |
Q27325382 | Transport of Gold Nanoparticles by Vascular Endothelium from Different Human Tissues |
Q42730813 | Tuning pharmacokinetics and biodistribution of a targeted drug delivery system through incorporation of a passive targeting component |
Q48888319 | Using Gold Nanoparticles To Disrupt the Tumor Microenvironment: An Emerging Therapeutic Strategy |
Q30524470 | X-ray imaging of tumor growth in live mice by detecting gold-nanoparticle-loaded cells |
Search more.